BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22364129)

  • 1. Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy.
    Mellana WM; Aronow WS; Palaniswamy C; Khera S
    Curr Pharm Des; 2012; 18(11):1450-6. PubMed ID: 22364129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Manifestations in Rheumatoid Arthritis.
    Sanghavi N; Ingrassia JP; Korem S; Ash J; Pan S; Wasserman A
    Cardiol Rev; 2024 Mar-Apr 01; 32(2):146-152. PubMed ID: 36729119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.
    Chighizola C; Schioppo T; Ingegnoli F; Meroni PL
    Curr Vasc Pharmacol; 2012 Sep; 10(5):639-46. PubMed ID: 22272912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heart and cardiovascular manifestations in rheumatoid arthritis.
    Voskuyl AE
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv4-7. PubMed ID: 16980723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
    Nurmohamed MT; van Halm VP; Dijkmans BA
    Drugs; 2002; 62(11):1599-609. PubMed ID: 12109923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?
    Pieringer H; Pichler M; Pohanka E; Hoppe UC
    Curr Pharm Des; 2014; 20(4):486-95. PubMed ID: 23565635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
    van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
    Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular diseases in rheumatoid arthritis].
    Nakajima A
    Nihon Rinsho; 2016 Jun; 74(6):1012-6. PubMed ID: 27311194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis (RA) and cardiovascular disease.
    Blum A; Adawi M
    Autoimmun Rev; 2019 Jul; 18(7):679-690. PubMed ID: 31059840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
    Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in rheumatoid arthritis.
    Sen D; González-Mayda M; Brasington RD
    Rheum Dis Clin North Am; 2014 Feb; 40(1):27-49. PubMed ID: 24268008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.
    Boyer JF; Cantagrel A; Constantin A
    Curr Vasc Pharmacol; 2008 Jul; 6(3):218-27. PubMed ID: 18673161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors in inflammatory arthritis.
    Mirjafari H; Al-Husain A; Bruce IN
    Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the cardiovascular disease burden in rheumatoid arthritis.
    Van Doornum S; Jennings GL; Wicks IP
    Med J Aust; 2006 Mar; 184(6):287-90. PubMed ID: 16548834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for cardiovascular disease in rheumatoid arthritis.
    Gabriel SE; Crowson CS
    Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of cardiovascular diseases in rheumatoid arthritis].
    Novikova DS; Popkova TV; Nasonov EL
    Ter Arkh; 2009; 81(5):88-96. PubMed ID: 19537595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid arthritis--a risk factor of ischemic heart disease].
    Hollan I; Mikkelsen K; Førre Ø
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3259-62. PubMed ID: 16327849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts.
    Avagimyan A; Fogacci F; Pogosova N; Kakturskiy L; Jndoyan Z; Faggiano A; Bairamyan T; Agati L; Sattar Y; Mkrchyan L; Avetisyan G; Ginosyan K; Aznauryan A; Sahakyan K; Trofimenko A; Urazova O; Mikhaleva L; Vandysheva R; Kogan E; Demura T; Kc M; Shafie D; Nicola S; Brussino L; Cicero A; Biondi-Zoccai G; Sarrafzadegan N
    Curr Probl Cardiol; 2024 Feb; 49(2):102230. PubMed ID: 38040221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.